CloudMine was a technology company that built a HIPAA-compliant Enterprise Health Cloud platform, enabling healthcare organizations to develop connected digital health experiences by simplifying data mobility, reducing complexity, and ensuring regulatory compliance.[1][2] It served providers, patients, clinical investigators, pharmaceutical firms, and digital innovators—such as the American Heart Association and Thomas Jefferson University Hospitals—solving key challenges in healthcare's digital transformation, including secure handling of electronic protected health information (ePHI).[1][3] The platform supported applications in disease management, clinical trials, and connected devices, with early recognition from industry analysts for its scalability and vision; however, CloudMine raised $18.98M before ceasing operations, marking its stage as "Dead."[2]
Founded in 2011 and headquartered initially in Philadelphia, Pennsylvania (with later mentions in Portland, Oregon), CloudMine emerged as a mobile backend-as-a-service (MBaaS) startup targeting the enterprise healthcare market.[1][2][4] Key leadership included CEO Stephen Wray, who positioned the company as a partner for providers building or adapting software tools amid rising demand for connected health solutions.[5] The idea took shape during the early 2010s boom in mobile health apps and data platforms, gaining early traction through HIPAA-compliant features that addressed compliance hurdles; pivotal moments included a 2018 platform upgrade expanding use cases to life sciences and clinical trials, though funding ended without further rounds.[1][2]
CloudMine rode the early 2010s wave of healthcare cloud infrastructure growth, coinciding with mobile health adoption, connected devices, and digital transformation pressures on providers.[1][2][5] Timing was ideal amid HIPAA demands and the shift to app-based care, positioning it against giants like AWS and IBM in a market projected to expand significantly (e.g., to $169B by 2028 at 18.8% CAGR).[2] It influenced the ecosystem by pioneering secure MBaaS for health data, paving the way for modern platforms in clinical trials and telehealth, though its demise highlights risks in niche healthcare tech amid funding challenges.[2][3]
CloudMine's story underscores the volatility of healthtech: a visionary HIPAA platform that scaled early but couldn't sustain post-$19M funding, ceasing operations amid competitive pressures.[2] No active future exists, but its legacy endures in today's booming healthcare cloud market, where trends like AI-driven trials and hybrid clouds amplify needs for compliant data tools it pioneered.[2] Survivors may evolve its model, influencing how startups balance innovation with enterprise demands—echoing its role as a bridge from mobile backends to connected care.
CloudMine has raised $7.0M in total across 1 funding round.
CloudMine's investors include Safeguard Scientifics.
CloudMine has raised $7.0M across 1 funding round. Most recently, it raised $7.0M Series A in March 2015.
| Date | Round | Lead Investors | Other Investors |
|---|---|---|---|
| Mar 1, 2015 | $7.0M Series A | Safeguard Scientifics |
